Filing Details
- Accession Number:
- 0000899243-20-031006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-13 17:00:27
- Reporting Period:
- 2020-11-11
- Accepted Time:
- 2020-11-13 17:00:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1731831 | Eidos Therapeutics Inc. | EIDX | Pharmaceutical Preparations (2834) | 463733671 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1758363 | Cameron Turtle | C/O Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2000 San Francisco CA 94104 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-11 | 3,005 | $73.56 | 62,526 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-11 | 9,497 | $74.75 | 53,029 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-11 | 908 | $75.23 | 52,121 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-11 | 1,500 | $0.00 | 50,621 | No | 5 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Direct |
Footnotes
- Represents the weighted average sale price of the shares sold from $73.08 to $74.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 through 3.
- Represents the weighted average sale price of the shares sold from $74.145 to $75.13 per share.
- Represents the weighted average sale price of the shares sold from $75.19 to $75.27 per share.
Billionaire Hedge Funds
